Literature DB >> 28267947

Ambu® AuraGain™ versus LMA Supreme™ Second Seal™: a randomised controlled trial comparing oropharyngeal leak pressures and gastric drain functionality in spontaneously breathing patients.

I I Shariffuddin1, W H Teoh2, Ebk Tang3, Nhm Hashim4, P S Loh4.   

Abstract

Newer second generation supraglottic airway devices may perform differently in vivo due to material and design modifications. We compared performance characteristics of the Ambu® AuraGain™ and LMA Supreme™ Second Seal™ in 100 spontaneously breathing anaesthetised patients in this randomised controlled study. We studied oropharyngeal leak pressures (OLP) (primary outcome) and secondarily, ease of insertion, success rates, haemodynamic response, time to insertion, and complications of usage. We found no significant difference in OLP between the AuraGain versus the LMA Supreme, mean (standard deviation, SD) 24.1 (7.4) versus 23.6 (6.2) cmH2O, P=0.720. First-attempt placement rates of the AuraGain were comparable to the LMA Supreme, 43/50 (86%) versus 39/50 (78%), P=0.906, with an overall 98% insertion success rate for the AuraGain and 88% for the LMA Supreme after three attempts, P=0.112. However, the AuraGain was deemed subjectively harder to insert, with only 24/50 (48%) versus 37/50 (74%) of AuraGain insertions being scored 1 = easy (on a 5 point scale), P=0.013, and also took longer to insert, 33.4 (SD 10.9) versus 27.3 (SD 11.4) seconds, P=0.010. The AuraGain needed a smaller volume of air (16.4 [SD 6.8] versus 23.0 [SD 7.4] ml, P <0.001) to attain intracuff pressures of 60 cmH2O, facilitated more successful gastric tube insertion (100% versus 90.9%, P=0.046), and had significantly decreased sore throat incidence (10% versus 38%, P=0.020). One AuraGain and six LMA Supremes failed to be placed within the stipulated 120 seconds trial definition of 'success'; these patients had risk factors for failed supraglottic insertion. In conclusion, both devices had similar OLPs and performed satisfactorily. However, the AuraGain resulted in less postoperative sore throat despite being harder to and taking longer to, insert.

Entities:  

Keywords:  Ambu AuraGain, LMA supreme, spontaneous breathing, oropharyngeal leak pressures, sore throat

Mesh:

Year:  2017        PMID: 28267947     DOI: 10.1177/0310057X1704500215

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  12 in total

1.  Comprehensive evaluation of manikin-based airway training with second generation supraglottic airway devices.

Authors:  Axel Schmutz; Erich Bohn; Johannes Spaeth; Sebastian Heinrich
Journal:  Ther Clin Risk Manag       Date:  2019-03-01       Impact factor: 2.423

2.  Effect of immobilised cervical spine on oropharyngeal sealing pressure with Ambu AuraGain™ Supraglottic airway: A randomised crossover trial.

Authors:  Duraiyarassu Uthaman; Suman Lata Gupta; Sandeep Kumar Mishra; Satyen Parida; Prasanna Udupi Bidkar; Muthupillai Senthilnathan
Journal:  Indian J Anaesth       Date:  2019-05

3.  Preliminary evaluation of SaCoVLM™ video laryngeal mask airway in airway management for general anesthesia.

Authors:  Chun-Ling Yan; Ying Chen; Pei Sun; Zong-Yang Qv; Ming-Zhang Zuo
Journal:  BMC Anesthesiol       Date:  2022-01-03       Impact factor: 2.217

Review 4.  A Literature Review of Factors Related to Postoperative Sore Throat.

Authors:  Yuta Mitobe; Yuri Yamaguchi; Yasuko Baba; Tomomi Yoshioka; Kenji Nakagawa; Takeshi Itou; Kiyoyasu Kurahashi
Journal:  J Clin Med Res       Date:  2022-02-24

5.  A study to compare Air-Q intubating laryngeal airway with Ambu Auragain laryngeal mask for blind tracheal intubation using Parker flex tip tube.

Authors:  Jatin Lal; Teena Bansal; Somesh Somesh; Mamta Jain
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2022-01-06

6.  Comparison of the clinical performance of the i-gelTM, LMA SupremeTM, and Ambu AuraGainTM in adult patients during general anesthesia: a prospective and randomized study.

Authors:  Tejashri Chinthavali Lakshmi; Tanmay Tiwari; Jyotsna Agrawal; Rajni Kapoor; Vikrannth Vasanthakumar
Journal:  Korean J Anesthesiol       Date:  2021-10-20

7.  Comparison of Gastric Insufflation Volume Between Ambu AuraGain and ProSeal Laryngeal Mask Airway Using Ultrasonography in Patients Undergoing General Anesthesia: A Randomized Controlled Trial.

Authors:  Adethen Gunasekaran; Kirthiha Govindaraj; Suman Lata Gupta; Stalin Vinayagam; Sandeep Kumar Mishra
Journal:  Cureus       Date:  2022-08-11

Review 8.  Extraglottic airway devices: technology update.

Authors:  Bimla Sharma; Chand Sahai; Jayashree Sood
Journal:  Med Devices (Auckl)       Date:  2017-08-17

9.  Comparision of Ambu AuraGain™ and LMA® ProSeal in children under controlled ventilation.

Authors:  Reesha Joshi; Priya Rudingwa; Pankaj Kundra; Sakthirajan Panneerselvam; Sandeep K Mishra
Journal:  Indian J Anaesth       Date:  2018-06

10.  Clinical performance of the LMA Protector™ airway in moderately obese patients.

Authors:  Ina Ismiarti Shariffuddin; Sook Hui Chaw; Ling Wei Ng; Ching Hooi Lim; Mohd Fitry Zainal Abidin; Wan A Wan Zakaria; Wendy H Teoh
Journal:  BMC Anesthesiol       Date:  2020-07-31       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.